3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
14
Ganglioneuroblastoma
3
Glioblastoma
2
Uterine Cervical Neoplasms
1
Small Cell Lung Carcinoma
1
Recurrence
1
Medulloblastoma
1
Lung Neoplasms
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia
1
Gliosarcoma
1
Glioma
1
Ependymoma
1
Central Nervous System Neoplasms
1
Carcinoma, Renal Cell
1
Brain Neoplasms
1
Interventions
X-Rays
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Phantoms, Imaging
5
Vincristine
4
Nuclear Medicine Department, Hospital
4
Doxorubicin
4
Dactinomycin
4
Radiotherapy
3
Biopsy
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
Vemurafenib
2
Radiotherapy, Conformal
2
Radiation
2
LY3023414
2
Etoposide
2
Cyclophosphamide
2
Carboplatin
2
thymoglobulin
1
sargramostim
1
pembrolizumab
1
lorvotuzumab mertansine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Wilms Tumor
×
Isotretinoin
×
Clear all
No trials found.